Skip to main content
Premium Trial:

Request an Annual Quote

Getting to the Clinic

Technology Review takes a look at Nanosphere's Verigene, a tool that uses both microfluidics and nanotechnology to screen DNA from a blood sample. "We believe the benefit of our system is that this simple cartridge format could be run in any hospital, even a doctor's office," the company's chief executive says. "We're moving complex testing to the point of patient care." Instead of testing taking days, Nanosphere is developing their product to do so in an hour or two.

"If it works, this could be a convenient way for physicians and coagulation clinics to incorporate pharmacogenomic information into warfarin dosing," adds Karen Weck, who directs UNC-Chapel Hill's molecular genetics laboratory.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.